Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C-type lectin domain family 5 member A (CLEC5A) is a type II transmembrane protein belonging to the C-type lectin receptor family, expressed predominantly on myeloid cells such as neutrophils, monocytes, macrophages, osteoclasts, microglia, and dendritic cells. Structurally, CLEC5A features a lectin-like domain and requires the adaptor protein DAP12 for signal transduction through the Syk kinase pathway; this is due to its short cytoplasmic tail that lacks signaling motifs. CLEC5A is a critical macrophage receptor for several viruses (notably dengue, influenza, and Japanese encephalitis virus): viral binding triggers DAP12 phosphorylation and causes secretion of pro-inflammatory cytokines, amplifying the innate immune response and contributing to diseases such as dengue hemorrhagic fever and dengue shock syndrome. CLEC5A also positively regulates osteoclastogenesis and participates in virus-induced pathology and inflammatory diseases. CLEC5A is under active investigation as a therapeutic target by blocking its activity (e.g., monoclonal antibodies, Syk inhibitors) to attenuate inflammatory damage in viral infections.
Blockade of ligand binding to CLEC5A inhibits downstream signaling and pro-inflammatory cytokine release; Syk pathway inhibition interrupts signal transduction after CLEC5A activation
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-type lectin domain family 5 member A (CLEC5A).